Figure 1From: Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer Representative immunohistochemistry of a basal-like breast tumor showing negative staining for the hormone receptors (ER and PR) and HER2 and positive staining for EGFR and CK5/6.Back to article page